Abstract
The development of a treatment strategy for the management of cancer pain is based on a patient evaluation that elucidates the pain syndrome and predominant pathophysiologic mechanism responsible for the pain. Coupled with evaluation of pain intensity, and the extent of functional and emotional disturbance, this assessment facilitates appropriate selection of primary and analgesic therapies to address the problem of patient distress.
Original language | English |
---|---|
Pages (from-to) | 57-78 |
Number of pages | 22 |
Journal | Hematology/Oncology Clinics of North America |
Volume | 10 |
Issue number | 1 |
DOIs | |
Publication status | Published - 1996 |
ASJC Scopus subject areas
- Oncology
- Hematology